This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Anxiety

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mg

Sponsored by Sandoz

About this trial

Last updated 8 years ago

Study ID

9153A

Status

Completed

Type

Interventional

Phase

Phase 1

Placebo

No

Accepting

18-75 Years
19 to 50 Years
Male
Male

Trial Timing

Ended 34 years ago

What is this trial about?

To demonstrate the relative bioavailability of Alprazolam tablets, 1 mg.

What are the participation requirements?

Yes

Inclusion Criteria

- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

No

Exclusion Criteria

- Positive test results for HIV or hepatitis B or C.

- Treatment for drug or alcohol dependence.